Catalyst Event
Bristol-Myers Squibb Co (BMY) · Other
From Akros U.S. High Dividend 20 Index (AUHDIV20)
8/17/2026, 12:00:00 AM
The U.S. FDA set a PDUFA target action date for iberdomide on 2026-08-17; importance is Low as the setting of a PDUFA date is a procedural event with minor price impact.
Korean Translation
2026년 8월 17일 미국 FDA의 이베르도마이드 신약 허가 신청에 대한 PDUFA 목표 심사 완료일 지정. 행정적 일정 확정으로 주가 영향이 적을 것으로 예상되어 중요도를 'Low'로 평가함.
Related Recent Events
The Bank of Nova Scotia (BNS) · Earnings Release
Q3 2026 earnings release scheduled for August 25, 2026. A 1-2% price impact is estimated upon the release scheduled.
8/25/2026, 12:00:00 AM
Target Corp (TGT) · Earnings Release
Target's Q2 2026 earnings release is set for August 19, 2026; low importance is estimated as the date announcement itself typically has a market impact of less than 5%, scheduled.
8/19/2026, 12:00:00 AM
Chevron Corp (CVX) · Earnings Release
Q2 2026 earnings release is scheduled for August 7, 2026; analysts forecast a significant increase in earnings due to higher oil prices and full integration of Hess assets. Market impact is estimated at Medium (5%) as earnings are a primary driver of stock volatility, scheduled.
8/7/2026, 12:00:00 AM
Manulife Financial Corp (MFC) · Earnings Release
Manulife is scheduled to release its Q2 2026 financial results after market close on August 5, 2026; low importance is estimated based on historical price volatility, scheduled.
8/5/2026, 12:00:00 AM
Comcast Corp (CMCSA) · Earnings Release
Comcast's Q2 2026 earnings release on July 30, 2026 scheduled. Medium importance is estimated as earnings reports often impact stock prices.
7/30/2026, 12:00:00 AM
Bristol-Myers Squibb Co (BMY) · Earnings Release
Bristol-Myers Squibb Q2 2026 earnings release on 2026-07-30 scheduled; importance is Low as the announcement of an earnings date typically has a <5% price impact.
7/30/2026, 12:00:00 AM